These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 36043682)
21. Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy. Darweesh O; Khatab N; Kheder R; Mohammed T; Faraj T; Ali S; Ameen M; Kamal-Aldin A; Alswes M; Al-Jomah N PLoS One; 2022; 17(11):e0274526. PubMed ID: 36399454 [TBL] [Abstract][Full Text] [Related]
22. COVID-19 vaccine hesitancy: A community-based research in Turkey. İkiışık H; Akif Sezerol M; Taşçı Y; Maral I Int J Clin Pract; 2021 Aug; 75(8):e14336. PubMed ID: 33973322 [TBL] [Abstract][Full Text] [Related]
23. A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India. Joshi A; Surapaneni KM; Kaur M; Bhatt A; Nash D; El-Mohandes A PLoS One; 2022; 17(6):e0269299. PubMed ID: 35679313 [TBL] [Abstract][Full Text] [Related]
24. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years. Puspitarani F; Sitaresmi MN; Ahmad RA Front Public Health; 2022; 10():999354. PubMed ID: 36388348 [TBL] [Abstract][Full Text] [Related]
25. Are COVID-19 mRNA vaccine side effects severe enough to cause missed work? Cross-sectional study of health care-associated workers. Cohen DA; Greenberg P; Formanowski B; Parikh PD Medicine (Baltimore); 2022 Feb; 101(7):e28839. PubMed ID: 35363178 [TBL] [Abstract][Full Text] [Related]
26. The impact of vaccine hesitation on the intentions to get COVID-19 vaccines: The use of the health belief model and the theory of planned behavior model. Li Z; Ji Y; Sun X Front Public Health; 2022; 10():882909. PubMed ID: 36311575 [TBL] [Abstract][Full Text] [Related]
27. Side effects after COVID-19 vaccinations among residents of Poland. Andrzejczak-Grządko S; Czudy Z; Donderska M Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078 [TBL] [Abstract][Full Text] [Related]
28. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ; Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777 [TBL] [Abstract][Full Text] [Related]
29. Predictors of COVID-19 vaccine acceptability among health professions students in Vietnam. Le CN; Nguyen UTT; Do DTH BMC Public Health; 2022 Apr; 22(1):854. PubMed ID: 35484522 [TBL] [Abstract][Full Text] [Related]
30. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa. Osuagwu UL; Mashige KP; Ovenseri-Ogbomo G; Envuladu EA; Abu EK; Miner CA; Timothy CG; Ekpenyong BN; Langsi R; Amiebenomo OM; Oloruntoba R; Goson PC; Charwe DD; Ishaya T; Agho KE BMC Public Health; 2023 Jan; 23(1):38. PubMed ID: 36609264 [TBL] [Abstract][Full Text] [Related]
31. COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey. Alibrahim J; Awad A Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444585 [TBL] [Abstract][Full Text] [Related]
32. COVID-19 Vaccine in Inherited Metabolic Disorders Patients: A Cross-Sectional Study on Rate of Acceptance, Safety Profile and Effect on Disease. Tummolo A; Dicintio A; Paterno G; Carella R; Melpignano L; De Giovanni D Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231528 [TBL] [Abstract][Full Text] [Related]
33. Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021. Segni MT; Demissie HF; Adem MK; Geleto AK; Kelkile MW; Sori BK; Heyi ML; Iticha DG; Bejiga GS; Guddisa AB; Sima YA; Amente LT; Bayisa DA; Hurisa MB; Jiru TK PLoS One; 2022; 17(12):e0278334. PubMed ID: 36480564 [TBL] [Abstract][Full Text] [Related]
34. Understanding COVID-19 vaccine hesitancy: A cross-sectional study in Malang District, Indonesia. Sujarwoto ; Maharani A; Holipah ; Andarini S; Saputri RAM; Pakpahan E; Oceandy D; Tampubolon G Front Public Health; 2022; 10():1030695. PubMed ID: 36777784 [TBL] [Abstract][Full Text] [Related]
35. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline. Tadfor Y; Nguyen-Hua N; Bennett H; Bos AJ; Smolinske SC Clin Toxicol (Phila); 2023 Jan; 61(1):77-83. PubMed ID: 36458888 [TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccination coverage in Egypt: a large-scale national survey - to help achieving vaccination target, March-May, 2022. Kandeel A; Eldeyahy I; Abu ElSood H; Fahim M; Afifi S; Abu Kamar S; BahaaEldin H; Ahmed E; Mohsen A; Abdelghaffar K BMC Public Health; 2023 Feb; 23(1):397. PubMed ID: 36849954 [TBL] [Abstract][Full Text] [Related]
37. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older. Choi YY; Kim MK; Kwon HC; Kim GH J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980 [TBL] [Abstract][Full Text] [Related]
38. Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020. Hwang SE; Kim WH; Heo J Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34614382 [TBL] [Abstract][Full Text] [Related]
39. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771 [TBL] [Abstract][Full Text] [Related]
40. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey. Wang K; Wong ELY; Ho KF; Cheung AWL; Chan EYY; Yeoh EK; Wong SYS Vaccine; 2020 Oct; 38(45):7049-7056. PubMed ID: 32980199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]